{"brief_title": "A Single Dose of a Marketed Drug Being Studied for a New Indication to Treat Surgical Site Infection Following Colorectal Surgery as Compared to a Marketed Drug Approved for This Indication (0826-039)", "brief_summary": "The objective of this study is to evaluate the safety and efficacy of a one time dose of an intravenous marketed drug being evaluated for a new indication as compared to a marketed drug already approved for the prevention of surgical site infection following colorectal surgery.", "detailed_description": "The duration of treatment is 1 day.", "condition": ["Colorectal Surgery"], "intervention_type": ["Drug", "Drug"], "intervention_name": ["MK0826, ertapenem sodium", "Comparator: cefotetan"], "criteria": "Inclusion Criteria: Male or female patients 18 years of age scheduled to undergo elective colon or colorectal surgery by laparotomy must meet the following criteria: - Surgery must be scheduled in advance. - There must be adequate time to complete preoperative bowel preparation", "gender": "All", "minimum_age": "18 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "mesh_term": ["Surgical Wound Infection", "Ertapenem", "Cefotetan"], "id": "NCT00090272"}